Uterine Fibroids Epidemiology Forecast

DelveInsight's 'Uterine fibroids - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Uterine fibroids epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Uterine fibroids Understanding

The DelveInsight Uterine fibroids epidemiology report gives a thorough understanding of the Uterine fibroids by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Uterine fibroids in the US, Europe, and Japan. The report covers the detailed information of the Uterine fibroids epidemiology scenario in seven major countries (US, EU5, and Japan).


Uterine fibroids Epidemiology Perspective by DelveInsight

The Uterine fibroids epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Uterine fibroids epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Uterine fibroids epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Uterine fibroids Detailed Epidemiology Segmentation

The Uterine fibroids epidemiology covered in the report provides historical as well as forecasted Uterine fibroids epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Uterine fibroids report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Uterine fibroids report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Uterine fibroids Epidemiology Report and Model provide an overview of the risk factors and global trends of Uterine fibroids in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Uterine fibroids in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Uterine fibroids
  • The report provides the segmentation of the Uterine fibroids epidemiology


Report Highlights

  • 11-Year Forecast of Uterine fibroids epidemiology
  • 7MM Coverage
  • Total Cases of Uterine fibroids
  • Total Cases of Uterine fibroids according to segmentation
  • Diagnosed cases of Uterine fibroids


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Uterine fibroids?
  • What are the key findings pertaining to the Uterine fibroids epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Uterine fibroids across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Uterine fibroids?
  • What are the currently available treatments of Uterine fibroids?


Reasons to buy

  • The Uterine fibroids Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Uterine fibroids market
  • Quantify patient populations in the global Uterine fibroids market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Uterine fibroids therapeutics in each of the markets covered
  • Understand the magnitude of Uterine fibroids population by its epidemiology
  • The Uterine fibroids Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Uterine fibroids

3. Uterine fibroids: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Uterine fibroids Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Uterine fibroids Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Uterine fibroids Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Uterine fibroids Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Uterine fibroids Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Uterine fibroids Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Uterine fibroids Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Uterine fibroids Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Uterine fibroids Treatment and Management

6.2. Uterine fibroids Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Uterine fibroids Epidemiology in 7MM (2017-2030)

Table 2 Uterine fibroids Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Uterine fibroids Epidemiology in the United States (2017-2030)

Table 4 Uterine fibroids Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Uterine fibroids Epidemiology in Germany (2017-2030)

Table 6 Uterine fibroids Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Uterine fibroids Epidemiology in France (2017-2030)

Table 8 Uterine fibroids Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Uterine fibroids Epidemiology in Italy (2017-2030)

Table 10 Uterine fibroids Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Uterine fibroids Epidemiology in Spain (2017-2030)

Table 12 Uterine fibroids Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Uterine fibroids Epidemiology in the United Kingdom (2017-2030)

Table 14 Uterine fibroids Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Uterine fibroids Epidemiology in Japan (2017-2030)

Table 16 Uterine fibroids Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Uterine fibroids Epidemiology in 7MM (2017-2030)

Figure 2 Uterine fibroids Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Uterine fibroids Epidemiology in the United States (2017-2030)

Figure 4 Uterine fibroids Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Uterine fibroids Epidemiology in Germany (2017-2030)

Figure 6 Uterine fibroids Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Uterine fibroids Epidemiology in France (2017-2030)

Figure 8 Uterine fibroids Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Uterine fibroids Epidemiology in Italy (2017-2030)

Figure 10 Uterine fibroids Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Uterine fibroids Epidemiology in Spain (2017-2030)

Figure 12 Uterine fibroids Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Uterine fibroids Epidemiology in the United Kingdom (2017-2030)

Figure 14 Uterine fibroids Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Uterine fibroids Epidemiology in Japan (2017-2030)

Figure 16 Uterine fibroids Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Uterine fibroids Epidemiology
  • Uterine fibroids
  • Uterine fibroids Pipeline
  • Uterine fibroids Companies
  • Uterine fibroids prevalent populat...
  • Uterine fibroids incident populati...
  • Uterine fibroids patients diagnose...
  • Uterine fibroids treatment algorit...

Forward to Friend

Need A Quote